1. Home
  2. VERU vs JG Comparison

VERU vs JG Comparison

Compare VERU & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • JG
  • Stock Information
  • Founded
  • VERU 1971
  • JG 2012
  • Country
  • VERU United States
  • JG China
  • Employees
  • VERU N/A
  • JG N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • JG Computer Software: Programming Data Processing
  • Sector
  • VERU Health Care
  • JG Technology
  • Exchange
  • VERU Nasdaq
  • JG Nasdaq
  • Market Cap
  • VERU 85.5M
  • JG 69.8M
  • IPO Year
  • VERU 1990
  • JG 2018
  • Fundamental
  • Price
  • VERU $3.60
  • JG $10.04
  • Analyst Decision
  • VERU Strong Buy
  • JG
  • Analyst Count
  • VERU 3
  • JG 0
  • Target Price
  • VERU $33.33
  • JG N/A
  • AVG Volume (30 Days)
  • VERU 227.6K
  • JG 12.0K
  • Earning Date
  • VERU 08-12-2025
  • JG 08-28-2025
  • Dividend Yield
  • VERU N/A
  • JG N/A
  • EPS Growth
  • VERU N/A
  • JG N/A
  • EPS
  • VERU N/A
  • JG N/A
  • Revenue
  • VERU $16,886,419.00
  • JG $46,938,193.00
  • Revenue This Year
  • VERU N/A
  • JG $10.90
  • Revenue Next Year
  • VERU N/A
  • JG N/A
  • P/E Ratio
  • VERU N/A
  • JG N/A
  • Revenue Growth
  • VERU 337.24
  • JG 17.73
  • 52 Week Low
  • VERU $2.64
  • JG $3.27
  • 52 Week High
  • VERU $14.20
  • JG $20.94
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.24
  • JG 41.55
  • Support Level
  • VERU $2.64
  • JG $8.84
  • Resistance Level
  • VERU $3.69
  • JG $9.10
  • Average True Range (ATR)
  • VERU 0.39
  • JG 0.38
  • MACD
  • VERU 0.02
  • JG 0.02
  • Stochastic Oscillator
  • VERU 40.27
  • JG 34.55

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

Share on Social Networks: